Search Results - "Loknatha"

Nimotuzumab provides survival benefit to patients with inoperable advanced squamous cell carcinoma of the head and neck: A randomized, open-label, phase IIb, 5-year study in Indian patients by Reddy, B.K.M, Lokesh, V, Vidyasagar, M.S, Shenoy, K, Babu, K.G, Shenoy, A, Naveen, T, Joseph, Bindhu, Bonanthaya, R, Nanjundappa, Bapsy, P.P, Loknatha, Shetty, Jayarama, Prasad, Krishna, Tanvir Pasha, C.R

“…Summary Objective Overexpression of epidermal growth factor receptor (EGFR) in many cancers makes it an attractive therapeutic target. This study evaluated the…”
Get full text

Plasmablastic lymphoma in immunocompetent and in immunocompromised patients: Experience at a regional cancer centre in India by Rudresha, A.H., Lakshmaiah, K.C., Agarwal, Ankit, Babu, K. Govind, Loknatha, D., Jacob, Linu Abraham, Babu, Suresh, Lokesh, K.N., Rajeev, L.K.

“…Abstract Introduction: Plasmablastic lymphoma (PBL) is a rare lymphoma associated with immunosuppression. It is strongly associated with immunosuppression…”
Get full text

Lifelong vegetarianism and breast cancer risk: a large multicentre case control study in India by Gathani, Toral, Barnes, Isobel, Ali, Raghib, Arumugham, Rajkumar, Chacko, Raju, Digumarti, Raghunadharao, Jivarajani, Parimal, Kannan, Ravi, Loknatha, Dasappa, Malhotra, Hemant, Mathew, Beela S

“…The lower incidence of breast cancer in Asian populations where the intake of animal products is lower than that of Western populations has led some to suggest…”
Get full text

Clinicopathological Profile of Pure Neuroendocrine Neoplasms of the Esophagus: A South Indian Center Experience by Saldanha, Smitha Carol, Kumar, Rekha V., Lokesh, K. N., Rajeev, Lakkavalli Krishnappa, Babu, Suresh, Jacob, Linu A., Kamath, Mangesh, Lakshmaiah, Kuntegowdanahalli Chinnagiriyappa, Lokanatha, D., Babu, Govind, Haleshappa, Rudresha Antapura

“…Purpose. Neuroendocrine neoplasms (NENs) of the esophagus are very uncommon with only a few studies published worldwide. Studies on clinical profile,…”
Get full text

Diffuse large B-cell lymphoma in elderly: Experience from a tertiary care oncology center in South India by Lokesh, K.N., Babu, M.C. Suresh, Lakshmaiah, K.C., Babu, K. Govind, Saldanha, Smitha C., Loknatha, D., Jacob, Linu Abraham, Vishwanath, S., Premalatha, C.S., P., Kiran R.

“…Abstract Introduction: Diffuse large B-cell lymphoma (DLBCL) is the most frequent non-Hodgkins lymphoma in the elderly. With the rising proportion of older…”
Get full text

Colorectal cancer presenting as bone metastasis by Suresh Babu, M C, Garg, Sunny, Lakshmaiah, K C, Babu, K Govind, Kumar, Rekha V, Loknatha, D, Abraham, Linu Jacob, Rajeev, L K, Lokesh, K N, Rudresha, A H, Rao, Suparna Ajit

“…Bone metastasis is a rare site of metastasis, seen in only 3.7-11% of clinical cases. Isolated bone involvement has been reported very rarely in literature…”
Get full text

Pharmacoeconomic benefit of cisplatin and etoposide chemoregimen for metastatic non small cell lung cancer: An Indian study by Kamath, Mangesh, Lakshmaiah, K, Babu, K, Loknatha, D, Jacob, Linu, Babu, Suresh

“…Background: The incidence of lung cancer is rising in developing countries like India. Due to unaffordability among the low socioeconomic status (SES)…”
Get full text

Efficacy of a reduced-dose rasburicase: Single-institution experience in India by Lakshmaiah, K, Babu, K, Rajeev, L, Loknatha, D, Abraham, Linu, Babu, M, Lokesh, K, Rudresha, A, Agarwal, Ankit

“…Background: Tumor lysis syndrome (TLS) is an oncological emergency associated with life-threatening metabolic abnormalities. Hyperuricemia is a feature of TLS…”
Get full text

Metastatic nonsmall cell lung cancer in South India: A regional demographic study by Lakshmaiah, K C, Kamath, M P, Babu, K G, Amirtham, U, Loknatha, D, Komaranchath, A S

“…Nonsmall cell lung cancer (NSCLC) has varying epidemiological patterns in different countries and also in different regions of each country. In a country with…”
Get full text

FIP1L1-PDGFRA +Ve Clonal Chronic Eosinophilic Leukemia; Low Burden Disease with Dramatic Response to Low Dose Imatinib by Kumar, A., Lakshmiah, K.C., Loknatha, A., Suresh, T.M., Linu, J., Govindbabu, A.

Get full text

Metastatic hormone receptor-positive breast cancer in CDK 4/6 era: An outcome audit by Lakkavalli, Rajeev, Pehalajani, Jitendra, Tirumala, Venkatesh, Babu, Govind, Loknatha, Dassappa, Jacob, Linu, Babu, Suresh, Rudresha, A, Kadabur, Lokesh, Saldanha, Smitha, Giri, G

“…Background: The treatment landscape of metastatic hormone receptor (HR) positive breast cancer has been changed in recent years. Availability of CDK 4/6…”
Get full text

Mantle cell lymphoma (MCL): A single-center experience from a tertiary care institute in south India by Sathyanarayanan, Vishwanath, Lakshmaiah, K.C., Lokesh, Kadabur Nagendrappa, Rama Rao, Clementina, TM, Suresh, Govind Babu, Kanaka, Chennagiri, Premalata, D, Loknatha, Jacob Abraham, Linu, Babu, Suresh

“…Abstract only…”
Get full text

CML in Elderly: Does Age Matter? by Lokesh, Kadabur Nagendrappa, Pehalajani, Jitendra Kumar, Loknatha, Dassappa, Jacob, Linu Abraham, Babu, M. C. Suresh, Rudresha, A. H., Rajeev, Lakkavalli Krishnappa, Smitha, S. C., Ashok, Khandare Pravin, Madhumathi, D. S.

“…The median age of diagnosis for chronic myeloid leukemia (CML) in India is 35 years on the contrary to western literature which is 47 years. The outcome of the…”
Get full text

Outcome of young adults with chronic myeloid leukemia treated with upfront imatinib: A single institutional experience by Govind K Babu, Aditi Thanky, Linu Abraham Jacob, M C Suresh Babu, Loknatha Dasappa, Sandip Ganguly

“…Background: Young adult patients with malignancy are a distinct group of the population. In addition to their ailment, psychosocial issues including fertility…”
Get full text

A case series of patients with de novo Philadelphia-positive acute myeloid leukemia at a tertiary care center in South India - clinical profile, outcomes, and review of literature by D Loknatha, Suparna Ajit Rao, K N Lokesh, K Govind Babu, M C Suresh Babu, K C Lakshmaiah

“…Introduction: Ph+ AML is a well-recognized , but rare entity that poses challenges to clinicians to differentiate it from Chronic myeloid leukemia in blast…”
Get full text

The Efficacy, Safety, and Cost Benefit of Olanzapine versus Aprepitant in Highly Emetogenic Chemotherapy: A Pilot Study from South India by Babu, Govind, Saldanha, Smitha Carol, Kuntegowdanahalli Chinnagiriyappa, Lakshmaiah, Jacob, Linu Abraham, Mallekavu, Suresh Babu, Dasappa, Loknatha, Kiran, Pretesh Rohan, Sreevatsa, Aparna, Appachu, Sandhya, Unnikrishnan, Vineetha, Arroju, Venugopal

“…Background. The efficacy, safety, and cost benefit of olanzapine (OLN) when compared to aprepitant (APR) in the prevention of chemotherapy induced nausea and…”
Get full text